Cannabinoid Receptor 1 Antagonism Demonstrates High Therapeutic Potential for the Treatment of Primary Sclerosing Cholangitis

Detalles Bibliográficos
Autores principales: Kennedy, Lindsey, Alpini, Gianfranco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073729/
https://www.ncbi.nlm.nih.gov/pubmed/35131175
http://dx.doi.org/10.1016/j.jcmgh.2022.01.009
_version_ 1784701350982975488
author Kennedy, Lindsey
Alpini, Gianfranco
author_facet Kennedy, Lindsey
Alpini, Gianfranco
author_sort Kennedy, Lindsey
collection PubMed
description
format Online
Article
Text
id pubmed-9073729
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90737292022-05-07 Cannabinoid Receptor 1 Antagonism Demonstrates High Therapeutic Potential for the Treatment of Primary Sclerosing Cholangitis Kennedy, Lindsey Alpini, Gianfranco Cell Mol Gastroenterol Hepatol Editorial Elsevier 2022-02-04 /pmc/articles/PMC9073729/ /pubmed/35131175 http://dx.doi.org/10.1016/j.jcmgh.2022.01.009 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial
Kennedy, Lindsey
Alpini, Gianfranco
Cannabinoid Receptor 1 Antagonism Demonstrates High Therapeutic Potential for the Treatment of Primary Sclerosing Cholangitis
title Cannabinoid Receptor 1 Antagonism Demonstrates High Therapeutic Potential for the Treatment of Primary Sclerosing Cholangitis
title_full Cannabinoid Receptor 1 Antagonism Demonstrates High Therapeutic Potential for the Treatment of Primary Sclerosing Cholangitis
title_fullStr Cannabinoid Receptor 1 Antagonism Demonstrates High Therapeutic Potential for the Treatment of Primary Sclerosing Cholangitis
title_full_unstemmed Cannabinoid Receptor 1 Antagonism Demonstrates High Therapeutic Potential for the Treatment of Primary Sclerosing Cholangitis
title_short Cannabinoid Receptor 1 Antagonism Demonstrates High Therapeutic Potential for the Treatment of Primary Sclerosing Cholangitis
title_sort cannabinoid receptor 1 antagonism demonstrates high therapeutic potential for the treatment of primary sclerosing cholangitis
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073729/
https://www.ncbi.nlm.nih.gov/pubmed/35131175
http://dx.doi.org/10.1016/j.jcmgh.2022.01.009
work_keys_str_mv AT kennedylindsey cannabinoidreceptor1antagonismdemonstrateshightherapeuticpotentialforthetreatmentofprimarysclerosingcholangitis
AT alpinigianfranco cannabinoidreceptor1antagonismdemonstrateshightherapeuticpotentialforthetreatmentofprimarysclerosingcholangitis

Ejemplares similares